Reuters logo
BRIEF-GSK's cervical cancer vaccine gets European Commission marketing authorisation
December 20, 2013 / 3:15 PM / in 4 years

BRIEF-GSK's cervical cancer vaccine gets European Commission marketing authorisation

Dec 20 (Reuters) - GlaxoSmithKline Plc : * GSK Cervarix two-dose schedule receives european marketing authorisation * European commission has granted marketing authorisation for its cervical

cancer vaccine Cervarix * Cervical cancer vaccine cervarix as a two-dose schedule for girls aged 9 to

14. *

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below